Helena Freire Haddad

Title: Helena Freire Haddad: Innovator in Anti-PEG Antibody Research

Introduction

Helena Freire Haddad is a prominent inventor based in Evanston, IL (US). She has made significant contributions to the field of biomedical research, particularly in the development of methods for assessing PEG-based therapies. Her innovative work has the potential to enhance drug testing and improve patient outcomes.

Latest Patents

Helena Freire Haddad holds a patent for an "Anti-polyethylene glycol (PEG) antibody mouse model for rigorous assessment of PEG-based therapies." This invention provides methods for creating an in vivo animal model that detects anti-poly(ethylene glycol) antibodies. The model is designed to test and screen drugs for adverse reactions, bioavailability, and immunogenicity before they are administered to human subjects. She has 1 patent to her name.

Career Highlights

Helena is affiliated with Northwestern University, where she conducts her research and contributes to the academic community. Her work is instrumental in advancing the understanding of PEG-based therapies and their implications in medical treatments.

Collaborations

Some of her notable coworkers include Evan A Scott and Guillermo A Ameer. Their collaborative efforts contribute to the innovative research environment at Northwestern University.

Conclusion

Helena Freire Haddad is a trailblazer in the field of biomedical research, with her patent on anti-PEG antibody models paving the way for safer and more effective therapies. Her contributions are vital to the ongoing advancements in drug development and patient care.